Ratings by UBS (Graham Doyle)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2026 | GE HealthCare | GEHC | Upgrade | Neutral (Sell) |
61.58 (61.59) |
0.02% | Details | |
| 1/15/2026 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
84.77 (61.58) |
-27.36% | Details | |
| 5/5/2025 | GE HealthCare | GEHC | Upgrade | Neutral (Sell) |
70.53 (61.59) |
-12.68% | Details | |
| 9/26/2024 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
92.21 (61.59) |
-33.21% | Details | |
| 7/2/2024 | GE HealthCare | GEHC | Maintain | Neutral (N/A) |
|
Details | ||
| 2/12/2024 | GE HealthCare | GEHC | Upgrade | Neutral (Sell) |
81.34 (92.21) |
13.36% | Details | |
| 11/27/2023 | GE HealthCare | GEHC | Downgrade | Sell (Neutral) |
73.60 (61.59) |
-16.32% | Details | |
| 4/26/2023 | GE HealthCare | GEHC | New Coverage | Neutral (N/A) |
87.79 (61.59) |
-29.84% | Details |
